Phibro Animal Health (PAHC) Net Cash Flow (2013 - 2026)

Phibro Animal Health has reported Net Cash Flow for 14 years, with the latest figure at $6.0 million in Q2 2026.

• On a quarterly basis, Net Cash Flow fell 6.86% year-over-year to $6.0 million in Q2 2026; TTM through Jun 2026 was -$9.1 million, a 533.64% decrease from a year earlier, with the FY2026 full-year figure at -$9.1 million, down 533.64% from the prior year.
• Net Cash Flow was $6.0 million for Q2 2026 at Phibro Animal Health, up from -$2.9 million in the prior quarter.
• The five-year high for Net Cash Flow was $21.1 million in Q2 2024, with the low at -$31.2 million in Q1 2023.
• Average Net Cash Flow over 5 years is -$39111.1, with a median of $3.0 million recorded in 2022.
• The sharpest annual moves came in 2022 and 2024: Net Cash Flow soared 755.51% in 2022, then tumbled 1010.17% in 2024.
• Over 5 years, Net Cash Flow stood at -$8.6 million in 2022, then gained by 6.7% to -$8.0 million in 2023, then jumped by 336.3% to $18.9 million in 2024, then tumbled by 188.84% to -$16.8 million in 2025, then soared by 135.86% to $6.0 million in 2026.
• The last three Net Cash Flow figures came in at $6.0 million (Q2 2026), -$2.9 million (Q1 2026), and -$16.8 million (Q4 2025), per Business Quant data.